OverviewChartNewsTraderScreen

UBS Call 610 LLY 21.06.2024/  CH1285189556  /

Frankfurt Zert./UBS
17/05/2024  09:28:08 Chg.-0.430 Bid09:41:34 Ask- Underlying Strike price Expiration date Option type
15.650EUR -2.67% -
Bid Size: -		 -
Ask Size: -		 ELI LILLY 610.00 - 21/06/2024 Call
GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
TeleTrader 05/06 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 04/06 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire 03/06 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire 03/06 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 24/05 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 24/05 Eli Lilly to reveal $5.3B production boost
GlobeNewswire 23/05 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 23/05 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 23/05 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
TeleTrader 21/05 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 16/05 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 16/05 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 16/05 HEPHAISTOS secures €10.3 M to reach the clinical stage
GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 13/05 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 09/05 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 08/05 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO